Table 4.

Intent-to-treat response and survival

End pointArm A: G3139Arm B: controlP
CR   .53 
 Events/n 135/254 142/252  
 Rate (95% CI) 0.53 (0.47-0.59) 0.56 (0.50-0.63)  
OS   .13* 
 Events/n 228/254 237/252  
 Median (95% CI), mo 9 (7.46-11.66) 9 (7.82-10.78)  
 1-y rate (95% CI) 0.43 (0.37-0.49) 0.4 (0.34-0.46)  
 2-y rate (95% CI) 0.22 (0.18-0.28) 0.18 (0.14-0.23)  
EFS   .80 
 Events/n 234/254 241/252  
 Median (95% CI), mo 3 (1.94-4.34) 3 (2.56-5.49)  
 1-y rate (95% CI) 0.22 (0.17-0.28) 0.24 (0.19-0.30)  
 2-y rate (95% CI) 0.13 (0.09-0.18) 0.09 (0.06-0.14)  
DFS   .26 
 Events/n 116/135 130/142  
 Median (95% CI), mo 8 (7.10-11.70) 8 (6.90-10.51)  
 1-y rate (95% CI) 0.4 (0.32-0.49) 0.37 (0.30-0.46)  
 2-y rate (95% CI) 0.24 (0.18-0.32) 0.16 (0.11-0.24)  
Early death rate during first 30 d of induction therapy   .81 
 All patients (95% CI) 0.13 (0.09-0.18) 0.12 (0.08-0.17)  
End pointArm A: G3139Arm B: controlP
CR   .53 
 Events/n 135/254 142/252  
 Rate (95% CI) 0.53 (0.47-0.59) 0.56 (0.50-0.63)  
OS   .13* 
 Events/n 228/254 237/252  
 Median (95% CI), mo 9 (7.46-11.66) 9 (7.82-10.78)  
 1-y rate (95% CI) 0.43 (0.37-0.49) 0.4 (0.34-0.46)  
 2-y rate (95% CI) 0.22 (0.18-0.28) 0.18 (0.14-0.23)  
EFS   .80 
 Events/n 234/254 241/252  
 Median (95% CI), mo 3 (1.94-4.34) 3 (2.56-5.49)  
 1-y rate (95% CI) 0.22 (0.17-0.28) 0.24 (0.19-0.30)  
 2-y rate (95% CI) 0.13 (0.09-0.18) 0.09 (0.06-0.14)  
DFS   .26 
 Events/n 116/135 130/142  
 Median (95% CI), mo 8 (7.10-11.70) 8 (6.90-10.51)  
 1-y rate (95% CI) 0.4 (0.32-0.49) 0.37 (0.30-0.46)  
 2-y rate (95% CI) 0.24 (0.18-0.32) 0.16 (0.11-0.24)  
Early death rate during first 30 d of induction therapy   .81 
 All patients (95% CI) 0.13 (0.09-0.18) 0.12 (0.08-0.17)  
*

One-sided P value.

or Create an Account

Close Modal
Close Modal